Startups
VSY Biotechnology is a progressive and innovative company that focuses on customer satisfaction by c
Overview
Location
Germany
Employees
201-500
Phone
+49 711 997606333
Founded date
2009
Mentions in press and media 13
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Apr 8, 2024 | VSY Biotechnology GmbH Announces Opening of New Office in Dubai | VSY Biotechnology GmbH, a leading company in the biotechnology sector, is pleased to announce the official opening of its new office in Dubai. The Middle East region, particularly Dubai, serves as a gateway to emerging markets offering acce... |
| Apr 8, 2024 | VSY Biotechnology GmbH gibt die Eröffnung eines neuen Büros in Dubai bekannt | Als führendes Unternehmen in der Branche der Biotechnologie freut sich VSY Biotechnology, die offizielle Eröffnung des neuen Büros in Dubai bekanntzugeben. Die Region Naher Osten, insbesondere Dubai, bietet Zugang zu vielfältigen Kundenstäm... |
| Mar 19, 2024 | Reviscon Mono 2 % von VSY Biotechnology erhält die Zulassung von Health Canada für Osteoarthritis | Reviscon Mono 2% VSY Biotechnology GmbH meldet, dass Health Canada Reviscon Mono 2% (2,4 ml), eine Injektionslösung gegen Arthroseschmerzen in Synovial-Gelenken, zugelassen hat. Unser Ziel ist es, unser Reviscon-Portfolio, insbesondere Revi... |
| Mar 19, 2024 | VSY Biotechnology’s Reviscon Mono 2% Receives Health Canada Approval for Osteoarthritis | Reviscon Mono 2% VSY Biotechnology announced Health Canada's approval of Reviscon Mono 2% (2.4 ml), a one-time injectable solution for osteoarthritis pain and mobility issues. We aim to establish our Reviscon portfolio, especially Reviscon ... |
| Feb 22, 2024 | VSY Biotechnology Partners with Great Place to Work® to Foster Exceptional Workplace Culture | VSY Biotechnology GmbH, a leading biotechnology company, announced its strategic collaboration with Great Place to Work®. By prioritizing effective leadership, meaningful values, and a deep foundation of trust, we aim to cultivate a workpla... |
| Feb 22, 2024 | Um eine außergewöhnliche Arbeitsplatzkultur zu fördern, arbeitet VSY Biotechnology mit Great Place to Work® zusammen | VSY Biotechnology GmbH gab seine strategische Zusammenarbeit mit Great Place to Work®. Als zweitgrößter legaler Hersteller von IOLs in Deutschland ist es unsere Vision, ein anerkannter Vorreiter bei der Förderung einer „Great Place to Work“... |
| Feb 15, 2024 | VSY Biotechnology stellt Enova Maestro® IOL auf dem ESCRS-Wintertreffen vor | VSY Biotechnology wird auf dem bevorstehenden ESCRS-Wintertreffen sein neuartiges ophthalmologisches Produkt Enova Maestro® IOL. LEINFELDEN-ECHTERDINGEN, GERMANY, February 15, 2024 /EINPresswire.com/ -- VSY Biotechnology GmbH, ein führendes... |
| Feb 14, 2024 | VSY Biotechnology to Launch Enova Maestro® IOL at ESCRS Winter Meeting | VSY Biotechnology GmbH is set to launch its novel ophthalmic product Enova Maestro® - Sinusoidal Trifocal Toric Preloaded IOL at the ESCRS Winter Meeting. Unlike conventional lenses with overlapping diffraction patterns, VSY Biotechnology’s... |
| Nov 14, 2023 | Varliciment: A Novel Anti-VEGF Agent for the Treatment of AMD by VSY Biotechnology GmbH | VSY Biotechnology GmbH is proud to announce the development of Varliciment, a novel anti-VEGF agent for the treatment of AMD. We're all set to kick off the Phase I clinical trial for Varliciment very soon. Upon successful completion of Phas... |
Show more
Reviews 0
FAQ about VSY Biotechnology
When was VSY Biotechnology founded?
VSY Biotechnology was founded in 2009.
What has the press written about VSY Biotechnology?
Parsers VC has collected 13 articles mentioning VSY Biotechnology, among them “VSY Biotechnology GmbH Announces Opening of New Office in Dubai” (Apr 8, 2024) and “VSY Biotechnology GmbH gibt die Eröffnung eines neuen Büros in Dubai bekannt” (Apr 8, 2024).
Is VSY Biotechnology still active?
Yes, VSY Biotechnology is active; its latest activity on Parsers VC dates from May 22, 2024.